Clarifying the Discussion Points in New Drug Application Reviews for Approval in Japan by a Government Advisory Council
Crossref DOI link: https://doi.org/10.1177/2168479017696271
Published Online: 2017-12-30
Published Print: 2017-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hattori, Yasuyuki
Hanaoka, Hideki
Uyama, Yoshiaki
Text and Data Mining valid from 2017-07-01
Article History
Received: 12 December 2016
Accepted: 17 January 2017
First Online: 30 December 2017